First oral-focused in silico acute toxicity profiling of BZ (3-quinuclidinyl benzilate, CAS: 6581-06-2): integrated qualitative hazard screening, quantitative oral t-LD50 prediction and heuristic interspecies scaling
Authors:
- 29 June 2026
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 437, 112221
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- A problem formulation framework for the application of in silico toxicology methods in chemical risk assessmentArchives of Toxicology, 2024
- Novel computational models offer alternatives to animal testing for assessing eye irritation and corrosion potential of chemicalsArtificial Intelligence in the Life Sciences, 2021
- Toxicological testing of syringaresinol and enterolignansCurrent Research in Toxicology, 2020
- Automated and standardized workflows in the OECD QSAR ToolboxComputational Toxicology, 2019
- The OECD QSAR Toolbox Starts Its Second Decade2018
- A comparison of cholinesterase inhibitors in the treatment of quinuclidinyl benzilate-induced behavioural deficit in rats performing the multiple T-mazeJournal of Applied Biomedicine, 2014
- Incapacitating chemicals - risk to the purpose and objectives of the Chemical Weapons Convention?Kontakt, 2014
- Interspecies Extrapolation2012
- Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical informationJournal of Computer-Aided Molecular Design, 2011
- Muscarinic cholinergic receptors in human infant forebrain: [3H]Quinuclidinyl benzilate binding in homogenates and quantitative autoradiography in sectionsDevelopmental Brain Research, 1985